- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 340.97M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 342.67M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 348.23M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 348.27M sh |
| Shares Outstanding | Q3 2025 · Sep 30, 2025 | 338.53M sh |
| Shares Outstanding | Q3 2025 · Dec 31, 2024 | 340.04M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $1.77B |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $980.67M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $2.66B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $1.4B |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $3.51B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $3.51B |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $1.67B |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $697.03M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.47B |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $1.17B |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $575.42M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.09B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $938.21M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $814.84M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $760.2M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $1.26B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $1.07B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.06B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $4.87B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $4.78B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $3.49B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.31B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $6.34B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $5.87B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $2.45 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $6.51 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $1.25 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $2.81 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $2.47 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $6.58 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $1.29 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $2.91 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $58.76M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $165.33M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $36.21M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $115.02M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $43.85M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $144.29M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $80.78M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $268.85M |
| Net Income | Q3 2025 · Sep 30, 2025 | $835.55M |
| Net Income | Q3 2025 · Sep 30, 2025 | $2.23B |
| Net Income | Q3 2025 · Jun 30, 2025 | $819.53M |
| Net Income | Q3 2025 · Mar 31, 2025 | $576.42M |
| Net Income | Q3 2025 · Sep 30, 2024 | $434.42M |
| Net Income | Q3 2025 · Sep 30, 2024 | $980.57M |
| Net Income | Q3 2025 · Jun 30, 2024 | $309.97M |
| Net Income | Q3 2025 · Mar 31, 2024 | $236.18M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $1.08B |
| Operating Income | Q3 2025 · Sep 30, 2025 | $2.88B |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $534.3M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $1.28B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $174.86M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $481.61M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $120.92M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $367.22M |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.41B |
| Revenue | Q3 2025 · Sep 30, 2025 | $3.82B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $835.19M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $2.22B |